doi: 10.1080/02713680500514636.
Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF)
Affiliations
- PMID: 16500768
- DOI: 10.1080/02713680500514636
Item in Clipboard
Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF)
Curr Eye Res.
2006 Feb.
Abstract
The effects of diced small interfering RNAs (siRNAs) designed for vascular endothelial growth factor (VEGF) on the expression of VEGF in human retinal pigment epithelial cell line ARPE-19 cells in vitro and on corneal angiogenesis in vivo were examined. The exposure to diced siRNAs significantly reduced the VEGF mRNA expression in ARPE-19 cells with minimal toxicity. In suture-induced corneal angiogenesis models, diced siRNAs minimized the severity of angiogenesis. Histological analysis displayed no particular tissue damage in the conjunctiva where siRNA was injected. The approach using diced siRNAs can be a new tool for various neovascular ocular diseases.
Similar articles
-
A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.Curr Eye Res. 2010 May;35(5):375-84. doi: 10.3109/02713681003597230. Curr Eye Res. 2010. PMID: 20450250
-
Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.Mol Vis. 2003 May 30;9:210-6. Mol Vis. 2003. PMID: 12789138
-
Inhibition of vascular endothelial growth factor gene expression by T7-siRNAs in cultured human retinal pigment epithelial cells.Chin Med J (Engl). 2005 Apr 5;118(7):567-73. Chin Med J (Engl). 2005. PMID: 15820087
-
Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders.Gene Ther. 2006 Mar;13(6):559-62. doi: 10.1038/sj.gt.3302653. Gene Ther. 2006. PMID: 16195702 Review.
-
Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy.Mol Interv. 2002 Jun;2(3):158-67. doi: 10.1124/mi.2.3.158. Mol Interv. 2002. PMID: 14993376 Review. No abstract available.
Cited by
-
Corneal neovascularization: an anti-VEGF therapy review.Surv Ophthalmol. 2012 Sep;57(5):415-29. doi: 10.1016/j.survophthal.2012.01.007. Surv Ophthalmol. 2012. PMID: 22898649 Free PMC article. Review.
-
Amphiphilic Polypeptides for VEGF siRNA Delivery into Retinal Epithelial Cells.Pharmaceutics. 2020 Jan 2;12(1):39. doi: 10.3390/pharmaceutics12010039. Pharmaceutics. 2020. PMID: 31906576 Free PMC article.
-
Progress toward in vivo use of siRNAs-II.Mol Ther. 2012 Mar;20(3):483-512. doi: 10.1038/mt.2011.263. Epub 2011 Dec 20. Mol Ther. 2012. PMID: 22186795 Free PMC article. Review.
-
Inhibition of proliferation, migration and tube formation of choroidal microvascular endothelial cells by targeting HIF-1alpha with short hairpin RNA-expressing plasmid DNA in human RPE cells in a coculture system.Graefes Arch Clin Exp Ophthalmol. 2008 Oct;246(10):1413-22. doi: 10.1007/s00417-008-0858-8. Epub 2008 Jun 4. Graefes Arch Clin Exp Ophthalmol. 2008. PMID: 18523795
-
Effect of shRNA-mediated knockdown of vascular endothelial growth factor on the proliferation of choroid-retinal endothelial cells under hypoxic conditions.Exp Ther Med. 2015 Sep;10(3):1019-1024. doi: 10.3892/etm.2015.2596. Epub 2015 Jun 25. Exp Ther Med. 2015. PMID: 26622432 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
